2021
DOI: 10.1016/j.ejmech.2020.113049
|View full text |Cite
|
Sign up to set email alerts
|

Design and structural optimization of novel 2H-benzo[h]chromene derivatives that target AcrB and reverse bacterial multidrug resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(17 citation statements)
references
References 38 publications
0
16
0
Order By: Relevance
“…The rise of multidrug resistance (MDR) of bacteria is a worldwide health problem, as hundreds of thousands of people die every year from bacterial infections. If actions are not taken, it is estimated that in less than 30 years, MDR bacteria will cause more deaths than cancer [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…The rise of multidrug resistance (MDR) of bacteria is a worldwide health problem, as hundreds of thousands of people die every year from bacterial infections. If actions are not taken, it is estimated that in less than 30 years, MDR bacteria will cause more deaths than cancer [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…Chromene and benzochromene derivatives represent an important class of oxygencontaining heterocyclic compounds. They exhibit a wide range of biological activities, such as antimicrobial [1][2][3][4], anti-influenza virus [5] anti-proliferative [6][7][8], anti-inflammatory, analgesic, and selective COX-2 inhibitory activities [9] and effects. Also, the small molecules of benzochromene derivatives apply their anticancer activities by binding to DNA, thereby damaging DNA structure, changing the replication of double helix DNA, hindering the division of cancer cells, and binding to DNA through covalent and/or noncovalent interactions [8,10].…”
Section: Introductionmentioning
confidence: 99%
“…There have been three mechanisms of resistance against quinolones, including mutations of topoisomerases, decreased membrane permeability, and active drug efflux. Hence, it is urgent to develop new candidates with low drug resistance trends. This study used reference drug norfloxacin as a positive control to test the drug resistance of S. A.…”
Section: Results and Discussionmentioning
confidence: 99%